For Professionals · Quick reference

ASRA anticoagulation & neuraxial timing

Hold-before and restart-after intervals for neuraxial blockade and deep peripheral blocks, across antiplatelets, heparins, warfarin and the DOACs — with the renal caveats that change them. Search an agent or print for the block list.

Medically reviewed by Dr. Saurabh Shukla, MBBS, DNB Anesthesiology · Last updated June 2026

Antiplatelet agents 11

Aspirin (low-dose, monotherapy)

Hold before

No restriction — may continue

Restart after

No restriction

NSAIDs (monotherapy)

Hold before

No restriction — may continue

Restart after

No restriction

Clopidogrel

Hold before

5–7 days

Restart after

Resume after catheter removed (loading dose ≥24 h; maintenance immediately)

Prasugrel

Hold before

7–10 days

Restart after

≥6 h after catheter removal

Ticagrelor

Hold before

5–7 days

Restart after

≥6 h after catheter removal

Ticlopidine

Hold before

10 days

Restart after

After catheter removal

Cilostazol

Hold before

2 days

Restart after

After catheter removal

Dipyridamole (extended-release)

Hold before

24 h

Restart after

After catheter removal

GP IIb/IIIa — abciximab

Caveat: Avoid neuraxial within ~4 wk of these agents

Hold before

24–48 h (until platelet function recovers)

Restart after

GP IIb/IIIa — eptifibatide / tirofiban

Caveat: Reduced clearance in renal impairment

Hold before

4–8 h

Restart after

Cangrelor

Hold before

3 h

Restart after

Unfractionated heparin 2

UFH — subcutaneous prophylaxis (≤5000 U BID/TID)

Caveat: Higher SC doses (>5000 U/dose or >15000 U/day): treat as therapeutic

Hold before

4–6 h and normal coagulation; check platelets if >4 days of therapy

Restart after

1 h

UFH — intravenous therapeutic

Hold before

4–6 h and normal aPTT / ACT

Restart after

1 h

Low-molecular-weight heparin (LMWH) 2

LMWH — prophylactic dose (e.g. enoxaparin 40 mg/day)

Caveat: CrCl <30: accumulates — extend interval / avoid

Hold before

12 h

Restart after

12 h after block, and ≥4 h after catheter removal

LMWH — therapeutic dose (e.g. enoxaparin 1 mg/kg BID)

Caveat: CrCl <30: markedly prolonged — extend / avoid

Hold before

24 h

Restart after

24 h after block / catheter removal

Vitamin K antagonist 1

Warfarin

Hold before

5 days and INR ≤1.4 (normalised)

Restart after

Resume per surgical plan; remove indwelling catheter only when INR <1.5

Direct oral anticoagulants (DOACs) 4

Rivaroxaban

Caveat: CrCl 30–<50: consider longer; avoid if <30

Hold before

72 h (prophylactic & therapeutic)

Restart after

6 h after needle / catheter

Apixaban

Caveat: Reduce/avoid with significant renal impairment

Hold before

72 h

Restart after

6 h after needle / catheter

Edoxaban

Caveat: Renally cleared — extend if impaired

Hold before

72 h

Restart after

6 h after needle / catheter

Dabigatran

Caveat: Predominantly renal — heavily CrCl-dependent; avoid if <30

Hold before

CrCl ≥80: 72 h · 50–79: 96 h · 30–49: 120 h

Restart after

6 h after needle / catheter

Parenteral thrombin / Xa agents 3

Fondaparinux

Caveat: Renally cleared — avoid in renal impairment

Hold before

Prophylactic dose: 36–42 h (single-pass atraumatic needle); avoid with indwelling catheter

Restart after

6–12 h

Argatroban

Caveat: Hepatically cleared

Hold before

Insufficient data — avoid; ensure normal aPTT

Restart after

Bivalirudin

Caveat: Partly renal — prolonged if impaired

Hold before

~10 h and normal aPTT

Restart after

Thrombolytics & herbals 2

Thrombolytics (alteplase / tPA, streptokinase)

Hold before

Avoid; ≥48 h and document fibrinogen recovery

Restart after

Garlic / Ginkgo / Ginseng

Hold before

No mandated interval — not a contraindication alone

Restart after

No restriction

Key sources

Intervals are general adult defaults and are modified by renal/hepatic function, the dose, and whether a catheter is indwelling. This page does not provide drug dosing. Always confirm against the current ASRA/ESAIC text and your institutional protocol before performing a block.